Woman appeals for help for son with cell disorder | Inquirer News

Woman appeals for help for son with cell disorder

When Renante Navarro was diagnosed with Langerhans cell histiocytosis (LCH) at the age of eight, doctors at Philippine General Hospital recommended a series of chemotherapy sessions for him.

He is now 13 years old but he has yet to complete the whole treatment cycle due to lack of funds.

Lorna Navarro, the boy’s mother, said that PGH doctors had told her that Renante’s condition was inborn.

Article continues after this advertisement

LCH is a disease characterized by the overproduction of immature Langerhans cells, a type of white blood cell that helps the body fight infection. The condition can lead to tumors or organ damage.

FEATURED STORIES

The son of a carpenter from Pangasinan who lives in Binondo, Manila, Renante needs to undergo six more chemotherapy sessions to complete the treatment cycle. Each session costs P6,000 each.

“I hope this will soon be over because I can tell he was in pain during each session. He would tell me: ‘Even if I am not feeling well, you insist on still bringing me to the hospital for treatment.’ He doesn’t like to undergo chemo anymore but we can’t do anything,” Lorna said.

Article continues after this advertisement

Lorna can be reached at 0908-6240131. Deposits can be made to her BDO bank account (number 000360100368).

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: charity case, Children

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.